PGEN$5.252.14%0.11
After Hours: 5.21-0.04 -0.76%
Precigen Inc (PGEN)
Date: 2026-11-03 16:00O: 5.34H: 5.38L: 5.06C: 5.25Vol: 9.712M
Precigen Inc stock is traded at $5.25, with a volume of 9,712,124. It is up +2.14% in the last 24 hours and down -38.52% over the past month. Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Previous Close:
$5.14
Open:
$5.34
24h Volume:
9,712,124
Relative Volume:
1.33
Market Cap:
$1.88B
Revenue:
$9.68M
Net Income/Loss:
-$250.64M
P/E Ratio:
-
EPS:
-$1.40
Net Cash Flow:
-$89.83M
1W Performance:
-14.63%
1M Performance:
-38.52%
6M Performance:
+28.68%
1Y Performance:
+26.20%
1-Day Range:
$5.06$5.38
1-Week Range:
$4.91$7.04
52-Week Range:
$3.04$8.98
Precigen Inc Stock (PGEN) Company Profile
Name
Precigen IncSector
HealthcareIndustry
BiotechnologyPhone
301-556-9900Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Precigen Inc Stock (PGEN) Upgrades & Downgrades
Precigen Inc Stock (PGEN) Financials Data
Precigen Inc Stock (PGEN) Insider Trading
- Thomasian Harry Jr.Sep 23 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $2.81
- #Shares
- 53,665
- Value ($)
- 150,714
- #Shares Total
- 311,914
- KINDLER JEFFREY BAug 26 '26Director
- Transaction
- Sale
- Cost
- $7.44
- #Shares
- 185,000
- Value ($)
- 1,376,400
- #Shares Total
- 17,100
- Jeffrey KindlerAug 26 '26Director
- Transaction
- Proposed Sale
- Cost
- $7.42
- #Shares
- 185,000
- Value ($)
- 1,372,700
- #Shares Total
- 0
- Shah Rutul RAug 25 '26Officer
- Transaction
- Proposed Sale
- Cost
- $7.50
- #Shares
- 15,342
- Value ($)
- 115,065
- #Shares Total
- 0
- Shah Rutul RAug 25 '26Chief Operating Officer
- Transaction
- Option Exercise
- Cost
- $2.33
- #Shares
- 15,342
- Value ($)
- 35,747
- #Shares Total
- 484,207
- Tennant PhilAug 25 '26Officer
- Transaction
- Proposed Sale
- Cost
- $7.50
- #Shares
- 79,166
- Value ($)
- 593,745
- #Shares Total
- 0
- Shah Rutul RAug 25 '26Chief Operating Officer
- Transaction
- Sale
- Cost
- $7.50
- #Shares
- 15,342
- Value ($)
- 115,065
- #Shares Total
- 468,865
- Tennant PhilAug 25 '26Chief Commercial Officer
- Transaction
- Option Exercise
- Cost
- $1.61
- #Shares
- 79,166
- Value ($)
- 127,457
- #Shares Total
- 221,158
- Tennant PhilAug 25 '26Chief Commercial Officer
- Transaction
- Sale
- Cost
- $7.50
- #Shares
- 79,166
- Value ($)
- 593,745
- #Shares Total
- 141,992
- Shah Rutul RAug 21 '26Chief Operating Officer
- Transaction
- Option Exercise
- Cost
- $2.33
- #Shares
- 34,658
- Value ($)
- 80,753
- #Shares Total
- 499,670
